Obstetrics, gynecology and reproductive medicine guidelines

Hepatitis

PubMed Free Full Text

Hepatitis C: treatment

Australia

• NSW Department of Health
  • Review of Hepatitis C Treatment and Care Services [2008]

Canada

• Technology Assessment Unit of the McGill University Health Centre
  • Should the McGill University Health Centre initiate an antiviral treatment programme for patients with Chronic Hepatitis C? [2002]

International

• Cochrane Library
  • Ribavirin monotherapy for chronic hepatitis C
  • Medicinal herbs for hepatitis C virus infection
  • Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
  • Interferon for interferon naive patients with chronic hepatitis C
  • Interferon for acute hepatitis C
  • Glucocorticosteroids for viral hepatitis C
  • Antiviral therapy for recurrent liver graft infection with hepatitis C virus

Sweden

• Swedish Council on Technology Assessment in Health Care
  • Combination therapy for chronic hepatitis C [2001]

United Kingdom

• British Society of Gastroenterology
  • Guidance on the Treatment of Hepatitis C incorporating the use of Pegylated Interferons [2003]

• Health Technology Assessment
  • Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation [2007]
  • Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation [2006]

• National Institute for Health and Clinical Excellence
  • Hepatitis C - peginterferon alfa and ribavirin [2010]
  • Hepatitis C - pegylated interferons, ribavarin and alfa interferon [2004]

United States of America

• American Association for the Study of Liver Diseases
  • An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [2011]

• National Guideline Clearinghouse
  • (1) Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. (2) Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. 2010 addendum. National Institute for Health and Clinical Excellence (NICE) [2010]

Articles in journals

• American Family Physician
  • Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C [2005]
  • Management of Hepatitis C: Evaluating Suitability for Drug Therapy [2004]

• BMC Gastroenterology
  • Nutrigenomics Therapy of Hepatitis C Virus Hepatosteatosis [2010]

• Brazilian Journal of Infectious Diseases
  • Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C [2009]

• Canadian Journal of Gastroenterology
  • The role of iron in the pathophysiology and treatment of chronic hepatitis C [2009]

• Chest
  • Hepatitis C Virus and the Lung: Implications for Therapy [2005]

• Clinical Infectious Diseases
  • Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence [2009]

• Clinical Journal of the American Society of Nephrology
  • Interferon for Hepatitis C Virus in Hemodialysis—an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response [2009]
  • The Kidney Transplant Recipient with Hepatitis C Infection: Pre- and Posttransplantation Treatment [2007]

• Clinics In Liver Disease
  • Caspase Inhibitors for the Treatment of Hepatitis C [2009]

• Critical Reviews in Immunology
  • Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling [2010]

• Current Opinion in Pharmacology
  • Hepatitis C: Recent Successes and Continuing Challenges in the Development of Improved Treatment Modalities [2009]

• Digestive Diseases and Sciences
  • Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis C: a Review of the Literature [2009]

• Expert Opinion on Drug Metabolism & Toxicology
  • Modeling Hepatitis C Virus Kinetics under Therapy using Pharmacokinetic and Pharmacodynamic Information [2009]

• Indian Journal of Medical Research
  • Hepatitis C virus: molecular biology & current therapeutic options [2010]

• Japanese Journal of Infectious Diseases
  • A Hepatitis C Virus-Host Interaction Involved in Viral Replication [2010]

• Journal of Antimicrobial Chemotherapy
  • Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs) [2009]
  • Is beta-interferon a promising therapeutic option for the management of hepatitis C? [2009]
  • Treating HCV with ribavirin analogues and ribavirin-like molecules [2006]
  • Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon? [2003]

• Journal of Hepatology
  • Treatment Failure in Hepatitis C: Mechanisms of nonresponse [2009]

• Liver Transplantation
  • Human Liver Transplantation As A Model To Study HCV Pathogenesis [2009]

• PLoS ONE
  • Treatment of Hepatitis C in Children: A Systematic Review [2010]

• Psychosomatics
  • Interferon-Induced Psychosis as a "Psychiatric Contraindication" to Hepatitis C Treatment: A Review and Case-Based Discussion [2010]

• Saudi Journal of Gastroenterology
  • Managing HCV Infection in Pediatric Age Group: Suggested Recommendations [2010]
  • Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag [2010]
  • Antiviral Therapy in HCV-infected Decompensated Cirrhotics [2010]

• Topics in HIV Medicine
  • Moving beyond interferon alfa: investigational drugs for hepatitis C virus infection [2010]

• Virologica Sinica
  • Hepatitis C Virus Experimental Model Systems and Antiviral drug Research [2010]

• Virology Journal
  • Prediction of prognostic biomarkers for Interferon-based therapy to Hepatitis C Virus patients : a metaanalysis of the NS5A protein in subtypes 1a, 1b, and 3a [2010]
  • Hepatitis C Treatment: current and future perspectives [2010]

• World Journal of Gastroenterology
  • Importance of hepatitis C virus-associated insulin resistance: Therapeutic strategies for insulin sensitization [2010]
  • Impact of alcohol on hepatitis C virus replication and interferon signaling [2010]
  • Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C [2010]
  • Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C [2009]
  • Targeting host factors: A novel rationale for the management of hepatitis C virus [2009]
  • Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3? [2009]
  • Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition [2008]
  • Is interferon-beta an alternative treatment for chronic hepatitis C? [2006]
  • Safety of interferon beta treatment for chronic HCV hepatitis [2004]

{Related topics}

• Guidelines
  • Hepatitis C